Full Length Research Paper
References
|
Aleksandr M, George C, Yan R, Thomas LM, Richa A, Alejandro AS (2008). Database indexing for production MegaBLAST searches. Bioinformatics 24(16):1757-1764. |
|
|
Brusch JL, Garvey T, Schmitt SK (2010). Typhoid Fever: Treatment and Medication. World Health Organization (WHO) guidelines Updated. 1-5. |
|
|
Cheesbrough M (2006). District Laboratory Pratice in tropical countries. 2nd ed. (2). Cambridge University, press. Uk. clxxxii+187 pp. |
|
|
Clinical and Laboratory Standards Institute (CLSI) (2014). Performance standards for antimicrobial susceptibility testing, 24th informational supplement. M100-S24 Clinical and Laboratory Standards Institute, Wayne, PA. |
|
|
Clinical and Laboratory Standards Institute, Guidelines (CLSI) (2011). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
|
|
Crump JA, Luby SP, Mintz ED (2004). The global burden of typhoid fever. Bulletin of the World Health Organization 82(5):346-353. |
|
|
D'Angelo RG, Johnson JK, Bork JT, Heil EL (2016). Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria. Expert Opinion on Pharmacotherapy 17(7):953-967. |
|
|
David LW, Frank GR (2000). Surveillance of antimicrobial resistance in Salmonella, Shigella and Vibrio cholerae in Latin America and the Caribbean: A collaborative project. Canadian Journal of Infectious Disease 11(4):181-186. |
|
|
DrugBank (2009). Showing drug card for Levofloxacin. Canada. |
|
|
Elumalai S, Muthu G, Selvam RE, Ramesh S (2014). Detection of TEM, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. Journal of Medical Microbiology 63(7):962-967. |
|
|
George A, Jacoby MD, Luisa S, Munoz-Price MD (2005). Mechanisms of disease: The New beta-Lactamases. New England Journal Medicine 352(4):380-91. |
|
|
Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A (2001). Reduced Fluoroquinolone Susceptibility in Salmonella enterica Serotypes in Travelers Returning from Southeast Asia. Journal of Antimicrobial Chemotherapy 7(6): 996. |
|
|
Haugum K, Aas L, Lindstedt BA (2006). Effect of quinolone atibiotics and chemicals on mutation types in Salmonella enterica serovars Enteritidis, Hadar and Virchow. Division for Infectious Diseases Control, Norwegian Institute of Public Health, N-0403 Oslo, Norway.1-5. |
|
|
Health Grove (2018). Typhoid Fever in Nigeria: Statistics on Overall Impact and Specific Effect on Demographic Groups. |
|
|
Hirose K, Hashimoto A, Tamura K, Kawamura Y, Ezaki T, Sagara H, Watanabe H (2002). DNA Sequence Analysis of DNA Gyrase and DNA Topoisomerase IV Quinolone Resistance-Determining Regions of Salmonella enterica Serovar Typhi and Serovar Paratyphi A. Antimicrobial Agents and Chemotherapy 46(10):3249-3252. |
|
|
Hopkins KL, Davies RH, Threlfall EJ (2005). Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. International Journal of Antimicrobial Agents 25(5):358-373. |
|
|
Johnson and Johnson (2004). United States Securities and Exchange Commission. USA Shareholder.com. xxviii +29pp. |
|
|
Johnson and Johnson (2009). Analysis of Sales by Business Segments. (PDF). Shareholder. +27 pp. |
|
|
Levy SB, Marshall B (2004) Antibacterial resistance worldwide: Causes, challenges and responses. National Medical 10(12):S122-S129. |
|
|
Lindtedt BA, Aas L, Kapperud G (2004). Geographically dependent distribution of gyrA gene mutations at codons 83 and 87 in Salmonella Hadar, and a novel codon 81 Gly to His mutation in Salmonella Enteritidis. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 112:165-171. |
|
|
Moubareck C, Daoud Z, Hakime NI, Hamze M, Mangeney N, Matta H, Mokbat JE, Rohban R, Sarkis DK, Populaire FD (2005). Countrywide spread of community-and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. Journal of Clinical Microbiology 43(7):3309-3313. |
|
|
Murray RK, Granner DK, Mayes PA, Rodwell VW (2006). Protein Synthesis and the Genetic Code. Harper's Illustrated Biochemistry (27 ed.). McGraw-Hill Medical i+378pp. |
|
|
Mweu E, English M (2008). Typhoid fever in children in Africa. Tropical Medicine and International Health 13(4):532-540. |
|
|
Onyenwe NE, Adeleke OE, Smith SI, Fowora MA, Mbata TI (2011) Detection of mutation in Gyrase gene (gyr A) that codes for point mutation in Floroquinolone resistant Salmonella enterica serotypes isolated from a hospital in South east Nigeria. Asian Journal Pharmaceutical and Health Sciences 2(4):517- 521. |
|
|
Onyenwe NE, Adeleke OE, Mbata TI, Udeji GN, Okoro JC (2012) Detection of Mutation in gyrA and parC Gene on Resistant Salmonella enterica Serovars. Isolated from Two Hospitals in South East Nigeria. British Microbiology Research Journal 2(4):264-276, |
|
|
Philippon A, Arlet B Jacoby GA (2002). "Plasmid-determined AmpC-type β-lactamases" Antimicrobial Agents and Chemotherapy 46(1):1-11. |
|
|
Pitout JDD, Laupland KB (2008). Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. The Lancet Infectious Diseases 8(3):159-166. |
|
|
Schneider K (2008). Stockholders' Newsletter Bayer AG. |
|
|
Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC (2005). CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumonia. Journal of Antimicrobial Chemotherapy 57(1):24-30. |
|
|
Threlfall EJ, Ward LR (2001). Decreased Susceptibility to Ciprofloxacin in Salmonella Enterica serotype Typhi, United Kingdom. Emerging Infectious Disease 7(3):448-450. |
|
|
Valverde A, Grill F, Veresa MC, Pintado V, Fernando B, Rafael C, Cobo J (2008). High rate of intestinal colonization with extended-spectrum-lactamase-producing organisms in household contacts of infected community patients. Journal of Clinical Microbiology 46(8):2796-2799. |
|
|
Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL (2015). Typhoid fever. The Lancet 385(9973):1136-1145. |
|
|
World Health Organization (WHO) (2015). Immunization, Vaccines and Biologicals: Typhoid. |
|
|
Yah SC (2010). Plasmid-Encoded Multidrug Resistance: A Case study of Salmonella and Shigella from enteric diarrhea sources among humans. Biological Resistance 43(2):141-148. |
|
|
Yujuan J, Ling JM (2006). CTX-M-producing Salmonella spp. in Hong Kong: An emerging problem. Journal of Medical Microbiology 55(9):1245-1250. |
|
|
Zheng Z, Scott S, Lukas W, Webb M (2000). A greedy algorithm for aligning DNA sequences. Journal of Computer Biotechnology 7(1-2): 203-214. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
